Among monotherapy expansion cohorts (n=21), ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, showing best-in-class potential ...
In this week's Toyota Talks, Lou is joined by ESPN First Take host (and FOX Chicago alumna) Shae Cornette. They discuss what Saturday's dramatic win over the Packers did for the national perception of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results